Monday, March 23, 2015 1:15:53 PM
No there is curently no partnership
Yes Merck is providing Keytruda for free in a USCF sponsored combo trial
Yes a partnership hinges on positive combo trial results
New information: combination trial will have a patient size of 40-50 patients and will be statistically significant. Interim data to be expected at the earliest by Q4 and if all parties agree to releasing.
Also, they are working on a device that can go anywhere in the body to electroporate. This can have significant value at a later stage.
In my humble opinion, Oncosec is putting eveything in place to be a big winner. But, all will depent on positive combo trial results!
I feel comfortable holding my shares to await the results. If it gets manipulated down again, I will add.
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM